Subliminal hypoglycemia therapy (subcoma therapy, modified insulin the
rapy) is rarely practised in modern psychiatry. This study reports on
the therapy of 105 patients (2619 single treatments) suffering from th
erapy-resistant schizophrenia. Evaluation was retrospective. Remarkabl
y, 46.7% of the patients responded positively to a 4-6 week course of
insulin therapy. In 26.6%, the effect was moderate. Tolerance ist good
.